US
If visiting the DiaSorin Site from a region that doesn't coincide with your location, some products may not be available. This is due to regulatory requirements and restrictions.
13/03/24 - 10:23
Diasorin submits LIAISON PLEX® Yeast Blood Culture Assay for the LIAISON PLEX® system to the U.S. FDA (530.89 KB)
Products
Molecular
03/03/24 - 19:32
Diasorin receives FDA 510(K) clearance for its LIAISON PLEX® system together with the LIAISON PLEX® Respiratory Panel (150.83 KB)
Products
Molecular
25/01/24 - 7:48
Diasorin announces that it submitted the LIAISON® LymeDetect® to the U.S. Food and Drug Administration in December 2023 (507.38 KB)
Products
Immunodiagnostic
06/11/23 - 15:44
Diasorin and Gilead Sciences collaborate to develop a Fully Automated Diagnostic Assay for Hepatitis Delta Virus on Diasorin’s LIAISON XL® for the U.S. Market (506.97 KB)
Products
Immunodiagnostic
17/07/23 - 7:03
DiaSorin launches the LIAISON® Legionella Urinary Ag assay in all countries accepting the CE Mark to improve diagnosis of legionnaires’ disease (510.4 KB)
Products
Immunodiagnostic
13/06/23 - 15:18
DiaSorin launches the LIAISON® B·R·A·H·M·S MR-proADM™ assay in all countries accepting the CE Mark (578.05 KB)
Products
Immunodiagnostic
17/03/23 - 22:05
DiaSorin Simplexa COVID Flu assay received U.S. FDA 510(K) clearance (155.02 KB)
Products
Molecular
09/11/22 - 7:04
DiaSorin Simplexa® cCMV Direct assay received U.S. FDA 510(K) clearance (134.99 KB)
Products
Molecular
07/11/22 - 7:12
DiaSorin commercializes molecular reagent for monkeypox virus (149 KB)
Products
Molecular
05/10/22 - 6:37
DiaSorin furthers its collaboration with BARDA for the LIAISON® NES (160.31 KB)
Products
Molecular
14/09/22 - 0:29
DIASORIN SIMPLEXA™ COVID-19 TEST RECEIVED U.S. FDA 510(K) CLEARANCE (194.22 KB)
Products
Molecular
14/07/22 - 20:00
DiaSorin receives FDA 510(k) clearance for its LIAISON® MeMed BV® test (160.88 KB)
Products
Immunodiagnostic
20/05/22 - 7:08
DiaSorin CE Marks their ARIES® Flu A/B & RSV+SARS-CoV-2 Lowplex Assay (106.16 KB)
Products
Molecular
08/03/22 - 7:13
DiaSorin announces CE Marking of the new NxTAG® Gastrointestinal Molecular Multiplex Pathogen Panel (105.47 KB)
Products
Molecular
13/01/22 - 7:24
DiaSorin releases an updated Simplexa™ SARS-CoV-2 Variants Direct molecular assay (RUO) for the detection of mutations associated with the Omicron variant (486.67 KB)
Products
Molecular
30/11/21 - 19:10
DiaSorin confirms effectiveness of its Molecular Diagnostic tests in light of new Omicron SARS-CoV-2 Variant (307.83 KB)
Products
Molecular
29/11/21 - 7:06
DiaSorin receives FDA approval for its LIAISON® QuantiFERON®-TB Gold Plus assay for use on the LIAISON® XS Analyzer (437.79 KB)
Products
Immunodiagnostic
23/11/21 - 7:10
DiaSorin launches LIAISON® MeMed BV®, the first high throughput blood test to differentiate between bacterial and viral infections, in countries accepting the CE Mark (412.77 KB)
Products
Immunodiagnostic
18/09/21 - 8:16
DiaSorin CE Marks its new Simplexa™ COVID-19 & Flu A/B Direct Assay for Detection and Differentiation of SARS-CoV-2 and Influenza in One Test (407.21 KB)
Products
Molecular
15/06/21 - 6:56
DiaSorin launches the first fully automated CLIA high-throughput solution for diagnosing Hepatitis E (307.58 KB)
Products
Immunodiagnostic
25/05/21 - 7:03
DiaSorin: launch of the LIAISON® Quick Detect COVID Ag assay, an antigen test to detect COVID-19 infection (402.64 KB)
Products
Immunodiagnostic
21/05/21 - 7:02
DiaSorin Releases an Assay for Rapid Identification of Mutations Associated with Circulating Variants of SARS-CoV-2 (393.69 KB)
Products
Molecular
20/05/21 - 8:27
DiaSorin’s LIAISON® SARS-CoV-2 TrimericS IgG test receives FDA Emergency Use Authorization for the U.S. market (506.2 KB)
Products
Immunodiagnostic
21/04/21 - 7:02
DiaSorin, in partnership with QIAGEN, launches the new LIAISON® LymeDetect® Assay based on QuantiFERON technology (621.42 KB)
Products
Immunodiagnostic
20/04/21 - 18:58
DiaSorin launches the LIAISON® IQ with a first test that detects IgG antibodies against SARS-COV-2 in markets accepting the CE Mark (403.5 KB)
Products
Immunodiagnostic
30/03/21 - 7:01
DiaSorin received BARDA funding to develop and achieve FDA regulatory authorization, for its LIAISON® SARS-CoV-2 Ag test (661.47 KB)
Products
Immunodiagnostic
29/03/21 - 7:02
DiaSorin has obtained FDA Emergency Use Authorization for its LIAISON® SARS-CoV-2 Ag for COVID-19 testing in the U.S. (494.1 KB)
Products
Immunodiagnostic
23/02/21 - 6:11
DiaSorin obtained FDA approval for two additional serology tests for Lyme Disease in the U.S. market (413.92 KB)
Products
Immunodiagnostic
11/01/21 - 18:43
DiaSorin launches with CE mark the LIAISON® SARS-CoV-2 TrimericS IgG test (418.29 KB)
Products
Immunodiagnostic
29/12/20 - 18:22
DiaSorin has received BARDA Funding in support of submitting the SIMPLEXA COVID-19 Direct Kit for 510(k) clearance (400.67 KB)
Products
Molecular
01/12/20 - 6:33
DiaSorin received FDA approval for its LIAISON® XL MUREX HIV Ab/Ag assay, completing the Hepatitis and Retrovirus offer in the US market (566.6 KB)
Products
Immunodiagnostic
26/10/20 - 18:30
DiaSorin launches with CE mark the LIAISON® SARS-CoV-2 Ag, a new high-throughput antigen test for COVID-19 detection in symptomatic patients (414.59 KB)
Products
Immunodiagnostic
01/10/20 - 7:45
DiaSorin received FDA approval on 6 Hepatitis B tests, completing its Hepatitis offer in the US market (395.31 KB)
Products
Immunodiagnostic
01/10/20 - 7:32
DiaSorin’s LIAISON SARS-CoV-2 IgM test receives FDA Emergency Use Authorization for the U.S. market (488.09 KB)
Products
Immunodiagnostic
16/09/20 - 7:25
DiaSorin Simplexa™ COVID-19 Direct molecular test CE marked for saliva specimens (477.67 KB)
Products
Molecular
07/09/20 - 18:22
FDA approval of Simplexa flu A_B & RSV Direct Gen II Assay (400.26 KB)
Products
Molecular
06/08/20 - 7:25
DiaSorin announces the launch of its new CE marked LIAISON Testosterone xt test for the dosage of testosterone (391.91 KB)
Products
Immunodiagnostic
09/07/20 - 7:27
DiaSorin will provide the UK Government with its LIAISON SARS-CoV-2 S1/S2 IgG serology kit for COVID-19 testing to run a national screening study (399.63 KB)
Products
Immunodiagnostic
07/07/20 - 7:22
DiaSorin CE marks their new Simplexa Flu A/B & RSV Direct Gen II Assay to run with the Simplexa COVID-19 Direct assay (490.1 KB)
Products
Molecular
30/06/20 - 7:25
DiaSorin announces the launch of its new LIAISON® SARS-COV-2 IgM test, a new fully automated serology kit available in Europe and in the U.S. to identify the immediate response to SARS-COV-2 in COVID-19 patients (397.37 KB)
Products
Immunodiagnostic
12/06/20 - 7:30
DiaSorin has CE marked its molecular's Simplexa™ Congenital CMV Direct Assay (478.6 KB)
Products
Molecular
03/06/20 - 14:16
The LIAISON® SARS-COV-2 S1/S2 IgG test received the approval for the commercialization in Brazil from ANVISA (397.21 KB)
Products
Immunodiagnostic
18/05/20 - 11:28
The LIAISON® SARS-COV-2 S1S2 IgG test is the first to receive the approval from Health Canada (308.26 KB)
Products
Immunodiagnostic
25/04/20 - 16:49
DiaSorin - FDA EUA and BARDA funding for SARS-CoV-2 IgG (403.66 KB)
Products
Immunodiagnostic
17/04/20 - 18:25
DiaSorin has CE marked its SARS-COV-2 IgG serology kit for COVID-19 (464.49 KB)
Products
Immunodiagnostic
07/04/20 - 7:14
IgG test to detect immune response to SARS-CoV-2 (394.92 KB)
Products
Immunodiagnostic
20/03/20 - 7:28
DiaSorin COVID-19 test has received FDA Emergency Use Authorization (397.04 KB)
Products
Molecular
13/03/20 - 17:16
DiaSorin received BARDA funding to develop a rapid COVID-19 test (403.34 KB)
Products
Molecular
10/03/20 - 8:20
DiaSorin - Development of Coronavirus test (404.03 KB)
Products
Molecular
16/12/19 - 14:10
Diasorin receives FDA clearance for Simplexa VZV Swab Direct Molecular assay (571.47 KB)
Products
Molecular
27/11/19 - 7:59
DIASORIN LAUNCHES THE LIAISON QUANTIFERON-TB GOLD PLUS ASSAY IN PARTNERSHIP WITH QIAGEN IN THE US MARKET (531.97 KB)
Products
Immunodiagnostic
11/11/19 - 9:46
DIASORIN LAUNCHES PRIMER PAIR FOR CANDIDA AURIS IN THE US MARKET (159.93 KB)
Products
Molecular
30/10/19 - 9:55
DIASORIN LAUNCHES LIAISON® XL ZIKA CAPTURE IgM II TEST FOR THE DETECTION OF ZIKA VIRUS IN THE US MARKET (579.27 KB)
Products
Immunodiagnostic
22/10/19 - 14:10
DIASORIN LAUNCHES LIAISON HCV TEST FOR HEPATITIS C DIAGNOSIS IN THE US MARKET (358.37 KB)
Products
Immunodiagnostic
24/09/19 - 10:10
DiaSorin launches VZV Direct molecular test in Europe (369.67 KB)
Products
Molecular
29/05/19 - 15:06
DiaSorin launches VZV DIRECT molecular test in the United States (360.87 KB)
Products
Molecular
06/05/19 - 15:19
DiaSorin launches ELASTASE-1 test for the diagnosis of chronic exocrine pancreatitis on LIAISON XL (416.77 KB)
Products
Immunodiagnostic
03/04/19 - 10:32
DiaSorin launches the anaemia panel on Liaison XL in Europe (416.47 KB)
Products
Immunodiagnostic
31/01/19 - 22:30
DiaSorin launches FDA-cleared LIAISON Calprotectin test in the US market (528.02 KB)
Products
Immunodiagnostic
03/01/19 - 13:30
DiaSorin launches Simplexa Bordetella Direct Molecular test in the United States (428.56 KB)
Products
Molecular
21/12/18 - 11:30
DiaSorin launches 3 new primer pairs for use in molecular testing (438.25 KB)
Products
Molecular
19/11/18 - 15:00
DiaSorin launches Simplexa Group B Strep Direct molecular assay in the United States (435.43 KB)
Products
Molecular
17/10/18 - 11:51
DiaSorin launches Simplexa Group B Strep Direct molecular assay in the european market (147.78 KB)
Products
Molecular
12/10/18 - 11:47
DiaSorin launches Simplexa VZV Direct molecular assay in the european market (444.81 KB)
Products
Molecular
17/09/18 - 11:28
DiaSorin launches the new LIASON quantiFERON-TB Gold Plus assay as an aid for latent tuberculosis detection in partnership with Qiagen (753.85 KB)
Products
Immunodiagnostic
27/07/18 - 12:00
DiaSorin launches Hepatitis Delta (HDV) test on LIAISON XL platform (735.03 KB)
Products
Immunodiagnostic
12/06/18 - 14:15
DiaSorin introduces primer pair reagents for use in molecular testing: Anaplasma phagocytophilum, Ehrlichia e Babesia (445.17 KB)
Products
Molecular
05/04/18 - 12:00
DiaSorin receives FDA clearance for the LIAISON BRAHMS PCT II GEN assay to detect severe bacterial infections (e.g. Sepsis) (737.88 KB)
Products
Immunodiagnostic
28/03/18 - 18:45
DiaSorin earns FDA clearence extending sample claims for Simplexa HSV 1 & 2 direct molecular test (442.69 KB)
Products
Molecular
12/12/17 - 13:15
DiaSorin launches a new SIMPLEXA BORDETELLA DIRECT molecular test (426.89 KB)
Products
Molecular
21/09/17 - 12:45
DiaSorin earned CE-mark extending sample claims for DiaSorin Molecular's Simplexa HSV 1 & 2 kit (738.62 KB)
Products
Molecular
28/07/17 - 14:45
DiaSorin launches 3 new primer pairs for use in molecular testing: PNEUMOCYSTIS JIROVECII, GROUP C STREPTOCOCCUS, and GROUP G STREPTOCOCCUS (427.51 KB)
Products
Molecular
10/07/17 - 13:30
DiaSorin launches IAM CBFB-MYH11, completing the diagnostic test menu for molecular screening of acute myeloid leukemia by Q-LAMP (197.68 KB)
Products
Molecular
23/05/17 - 11:45
DiaSorin launches the new Liaison SHBG test for the diagnosis of androgen-related disorders (735.43 KB)
Products
Immunodiagnostic
16/05/17 - 13:00
DiaSorin launches the new Liaison Androstenedione test for the evaluation of adrenal and gonadal functionality (429.25 KB)
Products
Immunodiagnostic
21/04/17 - 18:45
DiaSorin receives authorization for the distribution of Zika IgM test in Europe (349.09 KB)
Products
Immunodiagnostic
06/04/17 - 18:00
DiaSorin receives FDA Emergency Use Authorization for the first, fully - automated Zika IgM test (376.16 KB)
Products
Immunodiagnostic
21/02/17 - 11:30
DiaSorin launches its new Simplexa C. Difficile direct molecular test in the US market (430.86 KB)
Products
Molecular
26/01/17 - 12:45
DIASORIN LAUNCHES THE LIAISON FGF 23 TEST, THE FIRST INNOVATIVE AND FULLY AUTOMATED MARKER FOR CHRONIC KIDNEY DISEASE (140.98 KB)
Products
Immunodiagnostic
02/11/16 - 1:00
DIASORIN LAUNCHES ITS FIRST MOLECULAR TEST WITH THE NEW BUSINESS DIVISION, DIASORIN MOLECULAR: THE NEW SIMPLEXA C. DIFFICILE DIRECT MOLECULAR TEST (141.53 KB)
Products
Molecular
22/08/16 - 2:00
DIASORIN PARTNERS WITH HHS TO FACE THE ZIKA EMERGENCY (158.39 KB)
Products
Immunodiagnostic
28/07/16 - 2:00
DiaSorin starts selling Vitamin D in Japan (724.4 KB)
Products
Immunodiagnostic
14/07/16 - 2:00
DiaSorin increases diagnostic test menu for molecular screening of Acute Myeloid Leukemia (278.18 KB)
Products
Molecular
07/06/16 - 2:00
DiaSorin launches the new Helicobacter pylori IgG CLIA test (518.61 KB)
Products
Immunodiagnostic
09/09/15 - 2:00
DiaSorin launches the two fastest molecular diagnostic tests in the world to detect fulminant leukemias (229.24 KB)
Products
Molecular
28/05/15 - 2:00
DiaSorin launches the test for Campylobacter (241.86 KB)
Products
Immunodiagnostic
29/04/15 - 2:00
DiaSorin - launches the test for Brahms-Sepsis (506.96 KB)
Products
Immunodiagnostic
14/04/15 - 2:00
DiaSorin launches the tests for Bordetella pertussis (187.11 KB)
Products
Immunodiagnostic
14/01/15 - 1:00
DiaSorin launches the test for Calprotectin (259.67 KB)
Products
Immunodiagnostic
16/12/14 - 1:00
FDA approves 1,25 Vitamin D in the US market (239.73 KB)
Products
Immunodiagnostic
09/12/14 - 1:00
DiaSorin launches its first onco-hematology test on LIAISON Iam: the BCR-ABL (265.26 KB)
Products
Immunodiagnostic
07/10/14 - 2:00
DiaSorin launches the test for HIV HT on LIAISON (267.4 KB)
Products
Immunodiagnostic
18/09/14 - 2:00
DiaSorin launches the stool test for Adenovirus on LIAISON (251.93 KB)
Products
Immunodiagnostic
30/06/14 - 2:00
DiaSorin launches the test for Herpes Simplex 1 and 2 on LIAISON IAM (250.1 KB)
Products
Immunodiagnostic
03/06/14 - 2:00
DiaSorin launches the test for Vitamin D 1,25 on LIAISON (265.57 KB)
Products
Immunodiagnostic
18/02/14 - 1:00
DiaSorin launches the new test for PTH on LIAISON (597.92 KB)
Products
Immunodiagnostic
11/02/14 - 1:00
DiaSorin launches the test for Rotavirus on stool sample (573.97 KB)
Products
Immunodiagnostic
24/01/14 - 1:00
DiaSorin obtains the approval of CLIA Hepatitis and Retrovirus tests in China (579.02 KB)
Products
Immunodiagnostic
09/01/14 - 1:00
DiaSorin launches the test for Cytomegalovirus on LIAISON IAM (174.61 KB)
Products
Immunodiagnostic
25/10/13 - 2:00
DiaSorin launches the EHEC Toxins test on stool samples (610.05 KB)
Products
Immunodiagnostic
10/10/13 - 2:00
DiaSorin launches the test for IgG to Trypanosoma Cruzi (Chagas) (615.28 KB)
Products
Immunodiagnostic
24/09/13 - 2:00
DiaSorin launches the hCG test on its LIAISON XL in the US (599.75 KB)
Products
Immunodiagnostic
24/07/13 - 2:00
DiaSorin launches the new test for Toxoplasmosis on LIAISON IAM (490.89 KB)
Products
11/07/13 - 2:00
DiaSorin obtains the approval of CLIA Hepatitis and Retrovirus tests in Brazil (113.84 KB)
Products
Immunodiagnostic
28/06/13 - 2:00
DiaSorin launches the test of Chlamydia Trachomatis IgG and IgA on LIAISON (78.13 KB)
Products
Immunodiagnostic
20/06/13 - 2:00
DiaSorin launches the new test for Parvovirus on LIAISON IAM (488.24 KB)
Products
Immunodiagnostic
17/04/13 - 2:00
FDA approves the Aldosterone assay (439.58 KB)
Products
Immunodiagnostic
07/02/13 - 1:00
Clostridium difficile on LIAISON (available outside the US and Canada only) (79.83 KB)
Products
Immunodiagnostic
29/01/13 - 1:00
Aldosterone on LIAISON (available outside the US and Canada only) (76.47 KB)
Products
Immunodiagnostic
10/04/12 - 2:00
Measles and Mumps IgM on LIAISON (available outside the US and Canada only) (43.59 KB)
Products
Immunodiagnostic
02/04/12 - 2:00
Helicobacter Pylori on stool on LIAISON (available outside the US and Canada only) (43.85 KB)
Products
Immunodiagnostic
02/02/12 - 1:00
FDA clearance for 25 OH Vitamin D on LIAISON (180.35 KB)
Products
Immunodiagnostic
12/01/12 - 1:00
New anti HBs II (available outside the US and Canada only) (196.83 KB)
Products
Immunodiagnostic
19/12/11 - 1:00
Clostridium Difficile toxins A and B in stool on LIAISON (available outside the US and Canada only) (192.66 KB)
Products
Immunodiagnostic
26/01/11 - 1:00
FDA approves the LIAISON XL (194.2 KB)
Products
Immunodiagnostic
02/12/10 - 1:00
Comment on position Paper on Vitamin D (53.46 KB)
Products
Immunodiagnostic
09/04/10 - 2:00
China approves new prenatal screening product line on LIAISON (141.08 KB)
Products
Immunodiagnostic
08/01/09 - 1:00
FDA clearance to five LIAISON products (96.84 KB)
Products
Immunodiagnostic